HemoShear Therapeutics
Charlottesville
About HemoShear Therapeutics
HemoShear Therapeutics develops new treatments for patients with rare metabolic disorders. It creates human-relevant systems to accurately replicate the biology of organ systems and diseases for use throughout drug discovery and development. They work strategically in partnerships with pharmaceutical, biotechnology, and medical device companies. It generates meaningful human response data to increase confidence in decision-making, reduce the risk of costly failures, and identify efficacious therapies.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $63.6M
- Funding stage: Early Stage Venture
- Last round: Debt Financing (Nov 2023)
- Website: hemoshear.com
- Phone: (434) 872-0196
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/hemoshear-therapeutics-74219 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.